Related Experiment Video
Updated: Jul 6, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Malignancy: an unrecognized risk factor for coronary stent thrombosis?
Alex R Hobson1, Daniel B McKenzie, Vijayalakshmi Kunadian
1Wessex Cardiac Unit, Southampton University Hospitals NHS Trust, Southampton S016 6YD, United Kingdom.
Stent thrombosis, a serious complication of coronary stenting, may be linked to cancer. Further research is needed to explore if malignancy is a risk factor for stent thrombosis.
Area of Science:
- Cardiovascular Medicine
- Oncology
Background:
- Stent thrombosis is a severe complication following coronary artery stenting, particularly with drug-eluting stents.
- The relationship between stent thrombosis and malignancy requires further elucidation.
Observation:
- A series of cases revealed stent thrombosis occurring in patients with known malignancy.
- Potential mechanisms linking malignancy and stent thrombosis were explored.
Findings:
- Malignancy may represent an underrecognized risk factor for stent thrombosis.
- Recurrent or unexplained stent thrombosis could indicate the presence of occult malignancy.
Implications:
- Investigating the association between malignancy and stent thrombosis is crucial.
- Clinicians should consider screening for occult malignancy in cases of unexplained or recurrent stent thrombosis.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Angina II: Classification
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations